Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 19 January, 2018

NuCana plc

NuCana Announces Promising Clinical Data at ASCO GI on NUC-1031 (Acelarin®) as Front-Line Treatment of Advanced Biliary Tract Cancer

YASTEST

a d v e r t i s e m e n t